Your browser doesn't support javascript.
loading
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant.
Waerlop, Gwenn; Janssens, Yorick; Jacobs, Bart; Jarczowski, Franziska; Diessner, André; Leroux-Roels, Geert; Klimyuk, Victor; Leroux-Roels, Isabel; Thieme, Frank.
Afiliação
  • Waerlop G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Janssens Y; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Jacobs B; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Jarczowski F; Icon Genetics GmbH, a Denka Company, Halle, Germany.
  • Diessner A; Icon Genetics GmbH, a Denka Company, Halle, Germany.
  • Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Klimyuk V; Icon Genetics GmbH, a Denka Company, Halle, Germany.
  • Leroux-Roels I; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Thieme F; Icon Genetics GmbH, a Denka Company, Halle, Germany.
Front Immunol ; 14: 1188431, 2023.
Article em En | MEDLINE | ID: mdl-37435073
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Norovirus Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Norovirus Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica